These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17353524)

  • 1. Politicians', bureaucrats' drug plans deemed too costly for public formularies.
    Kondro W
    CMAJ; 2007 Mar; 176(6):755. PubMed ID: 17353524
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug reimbursement policies in Canada--need for improved access to critical therapies.
    LeLorier J; Bell A; Bougher DJ; Cox JL; Turpie AG
    Ann Pharmacother; 2008 Jun; 42(6):869-73. PubMed ID: 18477735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forget US politicians' promises--Canada still cheap-drug mecca.
    Korcok M
    CMAJ; 2002 Oct; 167(9):1044. PubMed ID: 12403755
    [No Abstract]   [Full Text] [Related]  

  • 5. Whither seniors' pharmacare: lessons from (and for) Canada.
    Morgan SG; Barer ML; Agnew JD
    Health Aff (Millwood); 2003; 22(3):49-59. PubMed ID: 12757272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do P&T committees have enough power? Plans and PBMs are divided about sharing drug prices with clinicians. Is it better to have an administrative committee determine the formulary?
    Cross M
    Manag Care; 2007 Apr; 16(4):39-42. PubMed ID: 17491288
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tick-off-formularies concerning single subsidy of certain drugs--with implemented criteria].
    Ugeskr Laeger; 2002 Dec; 164(51):6094-5. PubMed ID: 12553155
    [No Abstract]   [Full Text] [Related]  

  • 8. Practitioners and health policy. Case of the Ontario Drug Benefit Plan.
    Shortt SE
    Can Fam Physician; 1995 Dec; 41():2053-60, 2070-6. PubMed ID: 8680287
    [No Abstract]   [Full Text] [Related]  

  • 9. Congress has its brain on drug benefits.
    Birnbaum JH
    Fortune; 2003 Jan; 147(1):178. PubMed ID: 12602124
    [No Abstract]   [Full Text] [Related]  

  • 10. Inter-provincial variation in government drug formularies.
    Grégoire JP; MacNeil P; Skilton K; Moisan J; Menon D; Jacobs P; McKenzie E; Ferguson B
    Can J Public Health; 2001; 92(4):307-12. PubMed ID: 11962119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy, politics, and public policy.
    Coster JM
    Am J Hosp Pharm; 1992 Jul; 49(7):1759-62. PubMed ID: 1621736
    [No Abstract]   [Full Text] [Related]  

  • 12. Senate GOP tosses drug bill. Law would have let Medicare negotiate costs directly.
    DoBias M
    Mod Healthc; 2007 Apr; 37(17):12. PubMed ID: 17479495
    [No Abstract]   [Full Text] [Related]  

  • 13. The formulary files. PBMs report increase in drug margins.
    Manag Care; 2006 Jan; 15(1):59. PubMed ID: 16502778
    [No Abstract]   [Full Text] [Related]  

  • 14. Waiting lists not pharmacare main issue: feds.
    Sibbald B
    CMAJ; 2004 Sep; 171(6):559. PubMed ID: 15367451
    [No Abstract]   [Full Text] [Related]  

  • 15. National pharmacare: a dog's tale.
    Anis AH
    CMAJ; 2004 Sep; 171(6):565-6. PubMed ID: 15367455
    [No Abstract]   [Full Text] [Related]  

  • 16. MMA formulary design requires health plans to control costs.
    Sipkoff M
    Manag Care; 2005 Jun; 14(6):18, 20. PubMed ID: 16044883
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceuticals & psychotropic drugs.
    Health Aff (Millwood); 2009; 28(3):723. PubMed ID: 19414880
    [No Abstract]   [Full Text] [Related]  

  • 18. Tiers reach new heights under Part D.
    Adler D
    Manag Care; 2006 Mar; 15(3):63-4. PubMed ID: 16604930
    [No Abstract]   [Full Text] [Related]  

  • 19. Trudeau signals support for Canadian pharmacare.
    Webster P
    Lancet; 2019 Jun; 393(10190):2482. PubMed ID: 31232361
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicare program: Medicare Advantage and prescription drug programs MIPPA drug formulary & protected classes policies. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2009 Jan; 74(11):2881-8. PubMed ID: 19385109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.